3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
49
Breast Neoplasms
39
Ovarian Neoplasms
35
Triple Negative Breast Neoplasms
24
Endometrial Neoplasms
20
Stomach Neoplasms
19
Squamous Cell Carcinoma of Head and Neck
17
Lung Neoplasms
17
Fallopian Tube Neoplasms
17
Esophageal Squamous Cell Carcinoma
15
Esophageal Neoplasms
15
Neoplasms
14
Neoplasm Metastasis
14
Parkinson Disease 4, Autosomal Dominant Lewy Body
13
Uterine Cervical Neoplasms
12
Carcinoma, Ovarian Epithelial
10
Head and Neck Neoplasms
7
Recurrence
6
Colorectal Neoplasms
6
Carcinoma
6
Adenocarcinoma
5
Uterine Neoplasms
4
Small Cell Lung Carcinoma
4
Oropharyngeal Neoplasms
4
Melanoma
4
Carcinoma, Transitional Cell
4
Carcinoma, Squamous Cell
4
Advanced Solid Tumors
4
Adenocarcinoma Of Esophagus
4
Peritoneal Neoplasms
3
Interventions
Blood Specimen Collection
5
Liquid Biopsy
2
Folfox protocol
2
Carboplatin
2
pertuzumab
1
Trastuzumab
1
Surgical Procedures, Operative
1
Standard of Care
1
Sevoflurane
1
Radiotherapy, Adjuvant
1
Propofol
1
Positron Emission Tomography Computed Tomography
1
Paclitaxel
1
Neoadjuvant Therapy
1
Mastectomy, Segmental
1
Gemcitabine
1
Fluorouracil
1
Epirubicin
1
Drug Therapy
1
Docetaxel
1
Cyclophosphamide
1
Colonography, Computed Tomographic
1
Cisplatin
1
Chemotherapy, Adjuvant
1
Capecitabine
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Neoplastic Cells, Circulating
×
Paclitaxel
×
Clear all
NCT04771871
2026-05-07
TARMAC
University College Hospital, Ibadan
Phase 2
Recruiting
42 enrolled